Can you tell me about the latest drug approval received by Lupin from the USFDA?

Lupin announced that it had secured approval from the US Food and Drug Administration or FDA to market Droxidopa capsules which is popularly used to treat dizziness. The USFDA has come for Droxidopa capsules having strength of 100 mg, 200 mg, and 300 mg. This is a generic version of Lundbeck's Northera capsules, which is also meant to treat dizziness. Lupin proposes to manufacture the drug at its Nagpur facility.